AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes
AI-Driven Multimodal Rehabilitation Framework for Type 2 Diabetes Integrating Digital Health Technologies, Intermittent Fasting, and Resistance Training to Optimize Metabolic and Functional Outcomes
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of an AI-driven multimodal rehabilitation framework combining digital health technologies, intermittent fasting, and resistance training in individuals with Type 2 Diabetes Mellitus (T2DM). The study will integrate mobile-based AI monitoring for glucose trends, physical activity tracking, and dietary adherence reminders, thereby improving patient engagement and self-management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2025
CompletedFirst Submitted
Initial submission to the registry
November 21, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
ExpectedJanuary 13, 2026
January 1, 2026
12 months
November 21, 2025
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
HbA1c (Biochemical Outcome)
HbA1c will be assessed from venous blood and reported as a percentage (%).
24 Months
HOMA-IR (Biochemical Outcome)
HOMA-IR will be derived from fasting glucose and fasting insulin measurements and presented as a unitless index.
24 Months
6-Minute Walk Test (Functional capacity; distance in meters)
The 6-Minute Walk Test (6MWT) measures functional capacity by recording the total distance (in meters) a person can walk in six minutes on a flat, straight course. Healthy adults typically walk between 400 and 700 meters,
24 Months
WHOQOL-BREF
The WHOQOL-BREF is a 26-item, self-report questionnaire developed by the World Health Organization (WHO) for measuring an individual's self-perceived quality of life. It is a widely used and cross-culturally validated abbreviated version of the original, more comprehensive WHOQOL-Score 0-100
24 Months
Diabetes Self-Management Questionnaire
Diabetes Self-Management Questionnaire (DSMQ), first reverse the scores for any negatively worded items so higher scores consistently indicate more effective self-care. Then, sum the scores for all items to get a raw total score. This raw score can be transformed to a scale of 0-10 by dividing the raw score by the theoretical maximum and multiplying by 10 for easier interpretation and comparison.
24 Months
Study Arms (2)
AI-Guided Multimodal Rehabilitation Program
EXPERIMENTALStandard Diabetes Care
ACTIVE COMPARATORInterventions
Digital Health: Mobile AI-based app with glucose tracking, exercise reminders, and fasting compliance monitoring Intermittent Fasting: 16:8 time-restricted feeding protocol, 5 days/week Resistance Training: 3 sessions/week (45 minutes), supervised + home-based program using elastic bands \& bodyweight
Usual pharmacological treatment + general lifestyle advice No structured AI, fasting, or exercise protocol
Eligibility Criteria
You may qualify if:
- Diagnosed with Type 2 Diabetes (≥1 year)
- HbA1c between 6.5% and 9.0%
- Sedentary or low physical activity levels
- BMI: 25-35 kg/m²
- Able to perform mild-to-moderate exercise
You may not qualify if:
- any other disability
- not willing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Superior University CRC
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2025
First Posted
January 13, 2026
Study Start
April 17, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share